ABSTRACT
Plants reputed to have cancer-inhibiting potential and putative active components derived from those plants have emerged as an exciting new field in cancer study. Some of these compounds have cancer-inhibiting potential in different clinical staging levels, especially metastasis. A few of them which stabilize cell-cell adhesions are controversial topics. This review article introduces some effective herbal compounds that target E-cadherin/β-catenin protein complex. In this article, at first, we briefly review the structure and function of E-cadherin and β-catenin proteins, Wnt signaling pathway, and its target genes. Then, effective compounds of the Teucrium persicum, Teucrium polium, Allium sativum (garlic), Glycine max (soy), and Brassica oleracea (broccoli) plants, which influence stability and cellular localization of E-cadherin/β-catenin complex, were studied. Based on literature review, there are some compounds in these plants, including genistein of soy, sulforaphane of broccoli, organosulfur compounds of garlic, and the total extract of Teucrium genus that change the expression of variety of Wnt target genes such as MMPs, E-cadherin, p21, p53, c-myc, and cyclin D1. So they may induce cell-cycle arrest, apoptosis and/or inhibition of Epithelial-Mesenchymal Transition (EMT) and metastasis.
Abbreviations
AJ | = | Adherens junction |
APC | = | Adenomatous polyposis coli |
CKI | = | Casein kinase I |
DATS | = | Diallyl trisulfide |
Dsh | = | Disheveled |
EMT | = | Epithelial-mesenchymal transition |
FAP | = | Familiar adenomatous polyps |
HAT | = | Histone acetyl transferase |
HDAC | = | Histone deacetylases |
MET | = | Mesenchymal-epithelial transition |
PKA | = | Protein Kinase A |
PP2A | = | Protein phosphatase 2A |
SAC | = | S-allylcysteine |
SAMC | = | S-allylmercaptocysteine |
SFN | = | Sulforaphane |
TMCH | = | Transmissible murine colonic hyperplasia |
TSA | = | Trichostatin A |
Acknowledgements
The authors specially thank Prof. Abasalt Hossienzadeh Colagar for critical reading of the manuscript.
Conflicts of interest
There are no conflicts of interest.